Summary for the 40-th Site(F) |
PID | QueryLength | FocusSite | TITLE |
676673 | 805 | 40 F | RecName: Full=Angiotensin-converting enzyme 2; EC=3.4.17.23 ;AltName: Full=Angiotensin-converting enzyme homolog ; Short=ACEH ;AltName: Full=Angiotensin-converting enzyme-related carboxypeptidase ; Short=ACE-related carboxypeptidase; EC=3.4.17.- ;AltName: Full=Metalloprotease MPROT15 ;Contains: RecName: Full=Processed angiotensin-converting enzyme 2 ;Flags: Precursor; |
AC/ID | AC:Q9BYF1 ID:ACE2_HUMAN |
Feature Table for 40-th site |
MUTAGEN: /note="F->D: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein." REGION: /note="Interaction with SARS-CoV spike glycoprotein" HELIX: VAR_SEQ: /note="MSSSSWLLLSLVAVTAAQSTIEEQAKTFLDKFNHEAEDLFYQSSLASWNYNT NITEENVQNMNNAGDKWSAFLKEQSTLAQMYPLQEIQNLTVKLQLQALQQNGSSVLSED KSKRLNTILNTMSTIYSTGKVCNPDNPQECLLLEPGLNEIMANSLDYNERLWAWESWRS EVGKQLRPLYEEYVVLKNEMARANHYEDYGDYWRGDYEVNGVDGYDYSRGQLIEDVEHT FEEIKPLYEHLHAYVRAKLMNAYPSYISPIGCLPAHLLGDMWGRFWTNLYSLTVPFGQK PNIDVTDAMVDQAWDAQRIFKEAEKFFVSVGLPNMTQGFWENSMLTDPGNVQKAVCHPT AWDLGKGDF -> MREAGWDKGG (in isoform 2)" /id="VSP_060903" DOMAIN: /note="Peptidase M2" CHAIN: /note="Processed angiotensin-converting enzyme 2" /id="PRO_0000292268" TOPO_DOM: /note="Extracellular" CHAIN: /note="Angiotensin-converting enzyme 2" /id="PRO_0000028570" |
Percentages of Amino Acids in Homologous Proteins [show alignment] |
L:38% S:17% F:14% W:13% T:12% I:7% |
Template For Monomer | predicted SecStr | predicted ExpBur | Predicted Relative Acc(%) |
7v61 | H (alpha-helix) | e (exposed) | 24.9 |
Predicted Bind Molecules |
hetero:14 metal:1 precipitant:3 |
Templates for 3D complexes |
hetero [9680 ] 8b9p_A_1_C_1 8b9p_B_1_D_1 [9589 ] 8bfw_A_1_B_1 8bfw_C_1_D_1 8byj_A_1_D_1 8byj_B_1_C_1 [10798 ] 8bn1_A_1_D_1 8bn1_B_1_C_1 [9785 ] 8toq_A_1_B_1 [9784 ] 8tor_A_1_B_1 8tot_A_1_C_1 8tot_B_1_D_1 8tou_A_1_B_1 [10392 ] 8tos_A_1_B_1 metal [CL ] 8df5_E_1_TA_1 precipitant [GOL ] 8asy_A_1_N_1 8asy_A_1_O_1 [EDO ] 9fmm_A_1_I_1 |
[Back to SiteTable] |
[Back to Search Page] |
[Back to Top Page] |